ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $485,000 | -35.6% | 17,399 | -20.6% | 0.01% | -38.5% |
| Q1 2017 | $753,000 | +97.1% | 21,912 | +82.6% | 0.01% | +116.7% |
| Q3 2016 | $382,000 | +72.9% | 12,000 | +51.8% | 0.01% | +50.0% |
| Q1 2016 | $221,000 | +5.7% | 7,904 | +58.1% | 0.00% | +33.3% |
| Q2 2015 | $209,000 | -74.4% | 5,000 | -80.0% | 0.00% | -75.0% |
| Q1 2015 | $815,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |